Acute cardiac care & resuscitation

Mid-regional pro-adrenomedullin and lactate levels for risk stratification in patients with out-of-hospital cardiac arrest

Eur Heart J Acute Cardiovasc CarePublished Prospective cohort study

Authors' conclusion

Higher MR-proADM concentrations are associated with an increased risk of death in patients with OHCA, and the combination of high MR-proADM and lactate levels identifies patients at a distinctly elevated risk.

Study context

Population
Patients with out-of-hospital cardiac arrest (OHCA) who survived at least 24 h after return of spontaneous circulation
Participants
232 patients
Exposure
High vs low mid-regional pro-adrenomedullin (MR-proADM) concentrations
Outcome
All-cause death
Follow-up
28 days

Main finding

As reported in the abstract

Death
Adjusted hazard ratio (95% CI)
Q4vs Q1-Q3multivariable adjusted, incl. lactate at 24 h
1.67(1.12–2.50)
1-unit increase in standardized MR-proADM
1.44(1.19–1.73)

Observational data: associations, not effects.

Further findings

Death, combination of high MR-proADM and high lactate (Q4)

Adjusted HR (95% CI)
High MR-proADM and high lactate (Q4)3.50 (1.92–6.39)

Biomarker levels at 24 h

Correlation of MR-proADM with lactate (weak)
r = 0.36, P < 0.001
Median MR-proADM 1.4 nmol/L (IQR 0.8-2.8 nmol/L)
Median lactate 1.8 mmol/L (IQR 1.3-3.4 mmol/L)

Original publication

Mid-regional pro-adrenomedullin and lactate levels for risk stratification in patients with out-of-hospital cardiac arrest. Eur Heart J Acute Cardiovasc Care. Published 21 March 2023. doi:10.1093/ehjacc/zuad029

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.